News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Reflect Scientific, Inc. Moving to New, Larger Facility


8/2/2011 9:03:18 AM

OREM, UT--(Marketwire - August 02, 2011) - Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, announced that the company will be moving to a larger facility to accommodate the growth of their liquid nitrogen cooling technology products.

"With this move Reflect will achieve two important objectives. The first is there will be additional floor space available that will be used for product development and manufacturing of the liquid nitrogen cooling technologies. The second is that Reflect will save approximately $140K over the 6-year term of the lease compared to our current facilities. The new facility is close by and moving expenses will be minimal," said Mr. Kim Boyce, CEO of Reflect Scientific. The new building is undergoing upgrades to accommodate the workflow and will be ready shortly. No disruption in business is expected.

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. For more information, visit www.reflectscientific.com.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.


Contact:

Thomas Tait
Vice President
719-357-5878


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES